-
Product Name
Ozuriftamab vedotin (Synonyms: CAB-ROR2-ADC (BA-3021); BA-302 CONJUGATED TO MONOMETHYL AURISTATIN E)
- Documents
-
Description
Anti-ROR2 Antibody (Ozuriftamab vedotin)
-
Tested applications
ELISA
-
Species reactivity
Human ROR2
-
Alternative names
CAB-ROR2-ADC (BA-3021) antibody; BA-302 CONJUGATED TO MONOMETHYL AURISTATIN E antibody
-
Isotype
IgG1
-
Preparation
Recombinant expression and purified from CHO cells.
-
Clonality
Monoclonal
-
Formulation
0.1 M Pro-Ac, 20 mM Arg, pH 5.0
-
Storage instructions
-80°C for 2 years under sterile conditions; -20°C for 1 year under sterile conditions; Avoid repeated freeze-thaw cycles.
-
Validations
SDS-PAGE
Anti-ROR2 Antibody (ozuriftamab vedotin) on SDS-PAGE under reducing (R) condition. The purity of the protein is greater than 95%.
SEC-HPLC
The purity of Anti-ROR2 Antibody (ozuriftamab vedotin) is 99.74%, determined by SEC-HPLC.
HIC-HPLC
The drug-to-antibody ratio (DAR) of the Anti-ROR2 Antibody (ozuriftamab vedotin) is 3.9.
ELISA
Immobilized ROR2 at 2 μg/mL (30 uL/well) can bind Anti-ROR2 Antibody (ozuriftamab vedotin)，EC50 is 0.160 ug/mL.
Related Products / Services
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"